Daily Multivitamin May Slow Cognitive Decline in Seniors

Researchers caution that it’s too soon to recommend supplements based on the results of a new study.

A black and white headshot of Andrew Carstens
| 2 min read
Woman holding a glass of water in one hand and pill in the other

© ISTOCK.COM, PRUDENCIOALVAREZ

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A clinical trial with more than 2,000 participants has found that cognition and memory function improved in adults over the age of 65 after they took a daily multivitamin for a three-year period. The authors of the study, published today (September 14) in Alzheimer’s & Dementia, write that their results represent the first large, long-term trial indicating that a multivitamin can improve cognition in older adults, but they note that further work is needed to confirm their findings in a more diverse cohort and to identify the mechanisms behind the potential benefit.

“We are excited because our findings have uncovered a new avenue for investigation—for a simple, accessible, safe, inexpensive intervention that could have the potential to provide a layer of protection against cognitive decline,” study author Laura Baker, a gerontologist at Wake Forest University, tells CNN, adding that the results do not mean senior adults should start taking multivitamins to protect their cognitive health: “It’s too soon to make these recommendations.”

The researchers separated the 2,262 participants ranging in age from 64 to 100 years—none of whom showed signs of cognitive impairment when they enrolled in the study—into four groups: one took a daily multivitamin plus a dose of cocoa extract containing flavonoids, another took only the cocoa supplement, a third took only the multivitamin, and the rest took only a placebo, reports STAT. The study was conducted as a so-called pragmatic trial, where researchers annually assessed participants’ cognitive function over mail and the phone—a practice designed to make research more accessible to those who couldn’t travel to the research site (though almost 90 percent of participants were white), the outlet reports.

See “Could Vitamin Supplementation Help Alzheimer’s Patients?

The results showed statistically significant improvements on brain function assessments in the groups taking multivitamins over the three years, whereas those taking only the cocoa extract showed no improvement, according to STAT. Scores improved even more in people with a history of cardiovascular disease, possibly because of the well-established link between heart and brain health, CNN reports.

Not everyone agrees that the results have real-world implications, however. “You could score a point better when you take the test a year later, and it’s statistically significant,” Jeff Kaye, who directs Oregon Health & Science University’s aging and Alzheimer’s center and was not part of the study, tells STAT. “But does that translate into anything meaningful in a person’s life?”

To estimate the clinical implications of their findings, the researchers compared how brain function changed over time between the groups, and found that multivitamins appeared to slow cognitive aging by 1.8 years over the three years, or by 60 percent. However, the authors write this estimate is based on an “imprecise yardstick” and requires more research to confirm.

The researchers are planning a future trial, with more diverse participants, to investigate the biological mechanisms behind how multivitamins may lower the risk of cognitive decline, STAT reports. “There are multiple pieces of that puzzle that throughout life may be contributing to that risk in later life,” Baker tells the outlet. “This is a piece of that puzzle. But it is a complex puzzle.”

Keywords

Meet the Author

  • A black and white headshot of Andrew Carstens

    Andy Carstens

    Andy Carstens is a current contributor and past intern at The Scientist. He has a bachelor’s degree in chemical engineering from the Georgia Institute of Technology and a master’s in science writing from Johns Hopkins University. Andy’s work has also appeared in Audubon, Slate, Them, and Aidsmap.
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide